Barry N. Heller

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen, Ajay Nirula, Barry N. Heller et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19

Robert Gottlieb, Ajay Nirula, Peter Chen et al. · JAMA · 2021 · 947 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +15

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

Michael Dougan, Masoud Azizad, Bharat Mocherla et al. · Clinical Infectious Diseases · 2021 · 68 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

Michael G. Ison, Joseph Fraiz, Barry N. Heller et al. · Antiviral Therapy · 2013 · 43 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

G. Ralph Corey, Jeffery S. Loutit, Greg Moeck et al. · Antimicrobial Agents and Chemotherapy · 2018 · 25 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13